PRINCETON, N.J., May 28, 2010 (GLOBE NEWSWIRE) -- Orchid Cellmark Inc. (Nasdaq:ORCH), a leading international provider of identity DNA testing services, today announced that Thomas A. Bologna, President and Chief Executive Officer of Orchid, is scheduled to present at the 2010 Bank of America Merrill Lynch Small and Mid Cap Conference in Boston on Tuesday, June 8, 2010 at 2:30 p.m. EDT.
Mr. Bologna will provide a brief corporate overview and discuss the company's recent and ongoing progress. A link to the live webcast of Mr. Bologna's presentation will be available in the Investors section of the company's website at http://www.orchidcellmark.com.
About Orchid Cellmark
Orchid Cellmark (Nasdaq:ORCH) is a leading international provider of DNA testing services primarily for forensic and family relationship applications. Orchid Cellmark is one of the largest providers of forensic DNA testing services and its DNA results are used by the criminal justice system to assist with the identification of perpetrators, the exclusion of suspects and the exoneration of wrongfully convicted individuals. The company provides DNA family relationship testing to numerous child services organizations and individuals seeking to verify parentage. Orchid Cellmark also serves immigration and security authorities for DNA testing of individuals. In the agriculture field, the company provides DNA testing services for selective trait breeding. Orchid Cellmark's strong market positions in these areas reflect the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the company's reputation for exceptional quality, reliability and customer service for nearly two decades. More information on Orchid Cellmark can be found at www.orchidcellmark.com.
CONTACT: Orchid Cellmark Inc. Investors: Thomas Bologna, CEO (609) 750-2324 email@example.com The Torrenzano Group Media: Ed Orgon (212) 681-1700 firstname.lastname@example.org